Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (281-290 of 455) with videos related to

Pageof 46
Sort By:
Cardiovascular Diabetology|May 25, 2016
Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trialMaelán Fontes-Villalba, Staffan Lindeberg, Yvonne Granfeldt, et al.
Diabetes Care|September 13, 2023
Empagliflozin Normalizes Fasting Hyperglycemia and Improves Postprandial Glucose Tolerance in Totally Pancreatectomized Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover StudyMille Baekdal, Sophie W Nielsen, Carsten P Hansen, et al.
Endocrine Connections|April 20, 2018
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolitesAnnieke C G van Baar, Andrei Prodan, Camilla D Wahlgren, et al.
Diabetes, Obesity & Metabolism|April 15, 2018
Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?Emilie S Andersen, Asger Lund, Jonatan I Bagger, et al.
Diabetes, Obesity & Metabolism|October 8, 2016
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trialPelle L Ishøy, Filip K Knop, Brian V Broberg, et al.
Diabetologia|March 25, 2019
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnanciesKarl Kristensen, Linda E Ögge, Verena Sengpiel, et al.
European Journal of Endocrinology|January 14, 2014
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humansMonika J Bak, Nicolai Wewer Albrechtsen, Jens Pedersen, et al.
Blood Purification|September 28, 2021
The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing HemodialysisTobias Bomholt, Marianne Rix, Thomas Almdal, et al.
International Journal of Cardiology|March 19, 2025
The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fractionAbdullahi A Mohamed, Daniel M Christensen, Milan Mohammad, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2024
Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy MenAndreas H Lange, Nina L Hansen, Miriam G Pedersen, et al.
Pageof 46

Showing results (281-290 of 455) with videos related to

Sort By:
Pageof 46
Cardiovascular Diabetology|May 25, 2016
Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trialMaelán Fontes-Villalba, Staffan Lindeberg, Yvonne Granfeldt, et al.
Diabetes Care|September 13, 2023
Empagliflozin Normalizes Fasting Hyperglycemia and Improves Postprandial Glucose Tolerance in Totally Pancreatectomized Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover StudyMille Baekdal, Sophie W Nielsen, Carsten P Hansen, et al.
Endocrine Connections|April 20, 2018
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolitesAnnieke C G van Baar, Andrei Prodan, Camilla D Wahlgren, et al.
Diabetes, Obesity & Metabolism|April 15, 2018
Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?Emilie S Andersen, Asger Lund, Jonatan I Bagger, et al.
Diabetes, Obesity & Metabolism|October 8, 2016
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trialPelle L Ishøy, Filip K Knop, Brian V Broberg, et al.
Diabetologia|March 25, 2019
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnanciesKarl Kristensen, Linda E Ögge, Verena Sengpiel, et al.
European Journal of Endocrinology|January 14, 2014
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humansMonika J Bak, Nicolai Wewer Albrechtsen, Jens Pedersen, et al.
Blood Purification|September 28, 2021
The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing HemodialysisTobias Bomholt, Marianne Rix, Thomas Almdal, et al.
International Journal of Cardiology|March 19, 2025
The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fractionAbdullahi A Mohamed, Daniel M Christensen, Milan Mohammad, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2024
Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy MenAndreas H Lange, Nina L Hansen, Miriam G Pedersen, et al.
Pageof 46